Cuvitru Prescribing & Dosing Schedule

Dosage & Administration Drug label Prior authorization Financial assistance Patient education People also ask

Cuvitru (immunoglobulin G, human)

CUVITRU 20 % in 10 mL Injection

BOXED WARNING

Dosage & Administration

For subcutaneous infusion only.

Administer at regular intervals from daily up to every two weeks (biweekly).

Individualize dose based on the patient's pharmacokinetic and clinical response.

Monitor serum IgG trough levels regularly to guide subsequent dose adjustments and dosing intervals as needed.

Switching from Immune Globulin Intravenous (Human) treatment (IGIV) or adult patients switching from HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase]:

* Begin treatment one week after the patient's last IGIV or HYQVIA infusion.
* Establish initial weekly dose by converting the monthly IGIV or HYQVIA dose into equivalent weekly dose and increasing it using a dose adjustment factor.

Initial Weekly dose =	Previous IGIVor HYQVIA dose (in grams) × 1.30
	No. of weeks between IGIVor HYQVIA doses.

* Frequent dosing (2-7 times per week): Divide the calculated weekly dose by the desired number of times per week.
* Biweekly dosing: Multiply the calculated weekly dose by 2.
Switching from Immune Globulin Subcutaneous (Human) treatment (IGSC):
* Weekly dose (in grams) should be the same as the weekly dose of prior IGSC treatment (in grams).
* Frequent dosing (2-7 times per week): Divide the calculated weekly dose by the desired number of times per week.
* Biweekly dosing: Multiply the calculated weekly dose by 2.
Infusion sites: up to 4 infusion sites simultaneously, with at least 4 inches between sites avoiding bony prominences. Rotate sites with each administration.

drug label

Cuvitru Prescribing Information

Report Adverse Event

prior authorization

Cuvitru Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Jun 26, 2024Arizona - Uniform Prior Authorization Form

Verified: Jun 26, 2024Colorado - Uniform Prior Authorization Form

Verified: Jun 26, 2024Hawaii - Uniform Prior Authorization Form

Verified: Jul 26, 2024Illinois - Uniform Prior Authorization Form

Verified: Jun 26, 2024Indiana - Uniform Prior Authorization Form

Verified: Jun 26, 2024Louisiana - Uniform Prior Authorization Form

Verified: Jun 26, 2024Minnesota - Uniform Prior Authorization Form

Verified: Jun 26, 2024New Hampshire - Uniform Prior Authorization Form

Verified: Jun 26, 2024New Mexico - Uniform Prior Authorization Form

Verified: Jun 26, 2024Oregon - Uniform Prior Authorization Form

Verified: Jun 26, 2024Texas - Uniform Prior Authorization Form

Verified: Jul 07, 2024Washington - Uniform Prior Authorization Form

Verified: Jul 07, 2024Wisconsin - Uniform Prior Authorization Form

Benefits investigation

Cuvitru One Path Start Form

financial assistance

Cuvitru Financial Assistance Options

Copay savings program

Cuvitru One Path Start Form

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

patient education

Cuvitru Patient Education

Getting started on Cuvitru

Instructions For Use: Primary Humoral Immunodeficiency (PI)

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Instructions For Use (Spanish): Primary Humoral Immunideficiency

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

About Cuvitru

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

About Cuvitru (Pediatrics)

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Side Effects

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Doctor Discussion Guide

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient Stories

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient Resources

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Infusion Log and Wellness Tracker

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Administration Guide

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

HelloCuvitru Patient Brochure

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Cuvitru FAQs

How is the dosage of Cuvitru ?Cuvitru is available in 5 dosages, including 200 mg/ml Injection 10 ml, 200 mg/ml Injection 20 ml, 200 mg/ml Injection 40 ml, 200 mg/ml Injection 5 ml and 200 mg/ml Injection 50 ml

What does Cuvitru treat?Cuvitru treats Immunologic Deficiency Syndromes

What is Cuvitru made of?Cuvitru contains immunoglobulin G which is a Human Immunoglobulin G

How Is Cuvitru Administered?Cuvitru is administered as a Injectable

What Are The Cuvitru Mechanism Of Action?Cuvitru mechanism of action is Antigen Neutralization

FAQ Data Source

Dosage & Administration

Dosage & Administration

drug label

Cuvitru Prescribing Information

prior authorization

Cuvitru Prior Authorization Resources

Most recent state uniform prior authorization forms

Benefits investigation

financial assistance

Cuvitru Financial Assistance Options

Copay savings program

patient education

Cuvitru Patient Education

Getting started on Cuvitru

Patient toolkit

people also ask

Cuvitru FAQs